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Background-—Red cell distribution width (RDW), a measure of the variability in size of circulating erythrocytes, is associated with
mortality and adverse outcome in selected populations with cardiovascular disease. It is scarcely known whether RDW is
associated with incident myocardial infarction (MI). We aimed to investigate whether RDW was associated with risk of ﬁrst-ever MI
in a large cohort study with participants recruited from a general population.
Methods and Results-—Baseline characteristics, including RDW, were collected for 25 612 participants in the Tromsø Study in
1994–1995. Incident MI during follow-up was registered from inclusion through December 31, 2010. Cox regression models were
used to calculate hazard ratios with 95% conﬁdence intervals for MI, adjusted for age, sex, body mass index, smoking, hemoglobin,
white blood cells, platelets, and other traditional cardiovascular risk factors. A total of 1779 participants experienced a ﬁrst-ever MI
during a median follow-up time of 15.8 years. There was a linear association between RDW and risk of MI, for which a 1%
increment in RDW was associated with a 13% increased risk (hazard ratio 1.13; 95% CI, 1.07 to 1.19). Participants with RDW above
the 95th percentile had 71% higher risk of MI compared with those with RDW in the lowest quintile (hazard ratio 1.71; 95% CI, 1.34
to 2.20). All effect estimates were essentially similar after exclusion of participants with anemia (n=1297) from the analyses.
Conclusion-—RDW is associated with incident MI in a general population independent of anemia and cardiovascular risk factors.
( J Am Heart Assoc. 2014;3:e001109 doi: 10.1161/JAHA.114.001109)
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R ed cell distribution width (RDW), a measure of thevariability in size of circulating erythrocytes,1 is calcu-
lated by automated blood cell counters as part of the routine
blood cell count analysis. Traditionally, RDW and mean
corpuscular volume (MCV) are used in the differential
diagnosis of anemia, particularly anemias that are microcytic
(caused by iron deﬁciency) or macrocytic (due to vitamin B12
or folate deﬁciency). An increased RDW can also result from
conditions that modify the shape of red blood cells due to the
premature release of immature cells into the bloodstream, to
hemoglobinopathies, or to other hematological diseases.2
Myocardial infarction (MI) remains a major cause of
morbidity and mortality worldwide.3,4 Consequently, identiﬁ-
cation of novel risk factors is of great potential value to
improve risk stratiﬁcation and facilitate targeted prevention of
MI. In a study from the National Health and Nutrition
Examination Survey (NHANES), a representative US popula-
tion, participants with RDW values above the 75th percentile
were aggregated in the highest 10-year Framingham risk
category for coronary heart disease.5 Other observational
studies in selected cohorts of patients with heart disease
have reported that RDW predicts all-cause mortality,6,7
cardiac morbidity and mortality,8,9 and adverse outcome in
patients with heart failure.10–12 Furthermore, RDW predicted
all-cause mortality and cardiovascular (CV) mortality in 2
population-based studies from NHANES.13,14
The association between RDW and MI has previously been
reported mainly in patients with known CV disease or heart
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failure.8–12 Although growing evidence supports the hypoth-
esis that high RDW is associated with an unfavorable CV risk
proﬁle and higher total and CV mortality in various popula-
tions, the impact of RDW on the risk of incident MI in a
general population is unclear. Consequently, we aimed to
investigate whether RDW was associated with risk of ﬁrst-ever
event of MI in a large prospective study with participants
recruited from a general population.
Material and Methods
Participants
Participants were recruited from the fourth survey of the
Tromsø Study, conducted in 1994–1995. The Tromsø Study is
a single-center, population-based, prospective study of total
birth cohorts and population samples, with repeated health
surveys of the inhabitants in Tromsø, Norway. Tromsø is the
largest city in the northern part of Norway. The population is
predominately urban, middle- class whites of Norwegian
origin. A detailed description of the study design and
population has been published earlier.15
All inhabitants aged 25 years and older were invited to
the survey. In total, 27 158 (77%) of the invited population
participated. We excluded 202 persons without written
consent, 688 persons with a previous history of MI, 43
persons not ofﬁcially registered as inhabitants of Tromsø, and
613 persons without RDW measurement. Overall, 25 612
persons (13 659 women and 11 953 men) were eligible for
the present study.
The study was conducted by the University of Tromsø
in cooperation with the National Health Screening Service.
The Regional Committee for Medical and Health Research
Ethics, the Data Inspectorate, and the Directorate of
Health and Social Affairs approved the study. Each participant
gave written informed consent prior to participation.
Baseline Measurements
Baseline information was collected by physical examinations,
blood samples, and self-administered questionnaires.
Height and weight were measured with participants wearing
light clothing and no shoes and using electronic scales. Body
mass index was calculated as kg/m2. Blood pressure was
recorded automatically in seated participants by trained per-
sonnel using the Dinamap Vital Signs Monitor. Three recordings
were taken, and the mean of the last 2 readings was used in this
analysis. Hypertension was deﬁned as systolic blood pressure
≥140 mm Hg or diastolic blood pressure ≥90 mm Hg or
self-reported use of antihypertensive medication.
Blood samples were collected from an antecubital vein.
For RDW, hemoglobin, white blood cells, platelets and MCV,
a 5-mL blood sample was drawn into vacutainer tubes
containing EDTA as the anticoagulant (K3-EDTA 40 lL,
0.37 mol/L per tube). These samples were analyzed within
12 hours in an automated blood cell counter (Coulter
Counter; Coulter Electronics). RDW was calculated as the
SD of MCV divided by MCV9100%. The analytical variation
coefﬁcient of RDW was less than 3%.
Serum and citrated plasma were prepared by centrifuga-
tion after 1 hour respite at room temperature. Nonfasting
serum total cholesterol and triglycerides were analyzed by
enzymatic colorimetric methods with commercial kits, as
described elsewhere.16 Serum high-density lipoprotein cho-
lesterol was measured after precipitation of lower density
lipoproteins with heparin and manganese chloride. The
Department of Clinical Chemistry, University Hospital of
North Norway, analyzed all blood samples.
Information on smoking habits and self-reported diabetes
was obtained from self-administered questionnaires. The
question on smoking read, “Do you smoke: Cigarettes or
cigars/cigarillos or pipe daily?” (“yes” means yes to any of
these 3 questions, “no” means no to all of these 3 questions).
The question on diabetes read, “Do you have or have you had
diabetes?” (yes or no).
Outcome Measurement of Myocardial Infarction
The unique Norwegian national 11-digit identiﬁcation number
allowed linkage to national and local diagnosis registries. All
ﬁrst-time events of MI were identiﬁed by linkage to the
diagnosis registries at University Hospital of North Norway
(outpatient diagnoses included) and the National Causes of
Death Registry at Statistics Norway. Cases of possible
incident nonfatal and fatal MI were identiﬁed by a broad
search for the International Classiﬁcation of Diseases, 9th
revision codes 410 to 414, 430 to 438, and 798 to 799 in the
period 1994–1998 and thereafter for the International
Classiﬁcation of Diseases, 10th revision codes I20 to I25,
I60 to I69, and R96, R98, and R99. University Hospital of
North Norway is the only hospital serving this community,
with the next hospital being located 250 km away by road
(148 km by air). The Causes of Death Registry covers
participants registered as living in Norway at the time of
their death, regardless of whether the death took place in
Norway or abroad.
All possible events of MI were validated by an independent
end point committee. The hospital medical records were
retrieved for case validation. Information from the National
Causes of Death Registry and from death certiﬁcates was
used to collect relevant information of the event from
additional sources such as autopsy reports and records from
nursing homes, ambulance services, and general practitio-
ners. We performed manual and/or electronic text searches
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in paper versions (used until 2001) and digital versions of
hospital records for notes on MI in all participants with 1
diagnosis or more of those mentioned above. A systematic
text search for MI was also performed in participants with one
of the diagnoses other than MI.
We included all incident events classiﬁed as deﬁnite,
probable, or possible MI, based on a classiﬁcation algorithm
that included clinical symptoms and signs, ﬁndings in
electrocardiograms, values of cardiac biomarkers, and
autopsy reports, when applicable (Table 1).17
Follow-up time was assigned from the date of examination
(1994–1995) to the date of ﬁrst-ever MI, date of death
(n=2845), date of migration from Tromsø (n=3811), or
through December 31, 2010, whichever came ﬁrst.
Statistics
The RDW values were divided into quintiles (quintile 1: 10.7%
to 12.2%; quintile 2: 12.3% to 12.5%; quintile 3: 12.6% to
12.8%; quintile 4: 12.9% to 13.2%; quintile 5: 13.3% to 30.5%).
The 95th percentile cut-off value of RDW was 14.3%.
Age-adjusted values of the different baseline variables across
quintiles of RDW were estimated using linear regression.
Tests for baseline differences of potential confounders
between those without and with incident MI were made using
2-sample t tests (continuous variables) or the chi-square test
(binary variables).
Crude incidence rates were calculated as the total number
of events divided by the total person-time and expressed as
events per 1000 person-years. Cox proportional hazards
regression models were used to estimate hazard ratios
(HRs) with 95% CIs of incident MI across quintiles of RDW or
RDW above the 95th percentile. Age was used as a time scale
in the analyses, and the lowest quintile of RDW was used as
the reference. Model 1 estimated the univariable associa-
tions. In model 2, we added other factors that could confound
the association (sex, body mass index, daily smoking,
hemoglobin, white blood cells, and platelet count). In model
3, we also included the following CV risk factors: hyperten-
sion, total cholesterol, triglycerides, diabetes, and red blood
cell count.
Finally, we analyzed RDW as a continuous variable and
estimated HR of MI per 1% increase in RDW. Multivariable
adjusted associations between RDW and MI were visualized
Table 1. Classiﬁcation Algorithm for Myocardial Infarction. The Tromsø Study
Definite MI Definite MI was defined by one of the following sets of conditions:
1. Typical, atypical, or inadequately described symptoms plus a definite new infarction in ECG recordings
2. Typical symptoms plus significantly higher myocardial enzyme and/or troponin levels
3. Atypical or inadequately described symptoms plus significantly higher myocardial enzyme and/or troponin levels plus
a probable new infarction in ECG recordings
4. Postmortem evidence of recent MI or thrombosis
Probable MI Probable MI was defined by one of the following sets of conditions:
1. Typical, atypical, or inadequately described symptoms plus probable new infarction shown in ECG recordings plus
moderately increased myocardial enzyme and/or troponin levels
2. Typical symptoms plus moderately higher myocardial enzyme and/or troponin levels
3. Atypical or inadequately described symptoms plus significantly higher myocardial enzyme and/or troponin levels
4. Atypical or inadequately described symptoms plus moderately higher myocardial enzyme and/or troponin levels plus
probable new infarction shown in ECG
5. Sudden death with no evidence of noncoronary cause of death
Possible MI An event that can be dated and for which secondary data of typical history in combination with ECG findings and/or
echocardiography and/or autopsy are consistent with MI but for which no primary data source is available
Unstable angina Angina at rest or minimal exertion and ST-depression or negative T-wave in ECG
Unclassifiable Increase in troponins or enzymes in relation to cardiac revascularization procedures (percutaneous coronary intervention
or coronary artery bypass grafting) or otherwise unclassifiable
Silent MI In the absence of clinical symptoms that can be dated:
1. New diagnostic Q-wave in incidental ECG, or
2. Evidence of MI on echocardiograph and/or multigated acquisition scan, or
3. Evidence of MI at autopsy
No MI The conclusion after the validation procedure is that the event does not fulfill the criteria for an acute coronary event
CABG indicates coronary artery bypass graft surgery; ECG, electrocardiography; MI, myocardial infarction; PCI, percutaneous coronary intervention.
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by an additive Cox regression plot. In this plot, RDW was
modeled with a smoothing spline with 4 degrees of freedom
ﬁt in a Cox proportional hazards model including the same
variables as in model 2.
The proportional hazards assumption was tested using
Schoenfeld residuals. Statistical interactions were tested by
including cross-product terms of sex and RDW or age and
RDW into the ﬁnal model (model 2). There were no sex
interactions. The number of participants included in the
different adjustment models varied slightly due to missing
data for covariates (in total 1.3% missing). P values <0.05
were regarded as statistically signiﬁcant. The statistical
packages R (version 2.15.1 for Windows; R Foundation),
SPSS (version 21 for Mac; IBM Corp) and STATA 12.1SE
(Stata Corp) were used.
Results
A total of 1779 participants (1080 men and 699 women)
experienced a ﬁrst-ever MI during a median follow-up time of
15.8 years. The crude incidence rate was 5.09 (95% CI, 4.85
to 5.33) per 1000 person-years.
Age at baseline and age-adjusted baseline characteristics
of the study participants across quintiles of RDW are shown in
Table 2. Mean age, body mass index, systolic and diastolic
blood pressure, serum total cholesterol, prevalence of daily
smokers, white blood cells, and platelets increased across
increasing RDW quintiles, whereas hemoglobin decreased.
Baseline characteristics of participants without and with
incident MI are shown in Table 3. Participants with MI were
older, had higher systolic and diastolic blood pressure, body
mass index, total cholesterol, triglycerides, hemoglobin, red
and white blood cell counts, and a higher proportion of daily
smokers and self-reported diabetes at baseline. High-density
lipoprotein cholesterol concentrations and platelet counts
were lower in the MI group. P values were <0.001 for
differences between groups for all variables.
When RDW was modeled as a continuous variable, a clear
linear dose-response relationship between RDW and risk of MI
was found (Figure). A 1% increment in RDW was associated
with a 16% increased risk of MI (HR 1.16; 95% CI, 1.11 to
1.21) after adjustment for age, sex, body mass index, daily
smoking, hemoglobin, white blood cells, and platelets (model
2). Further adjustment for hypertension, total cholesterol,
Table 2. Baseline Characteristics by Quintiles of Red Cell Distribution Width. The Tromsø Study
Red cell distribution width Quintile 1 Quintile 2 Quintile 3 Quintile 4 Quintile 5
N 5081 4702 4886 4900 6043
Median, % (range) 12.0 (10.7 to 12.2) 12.4 (12.3 to 12.5) 12.7 (12.6 to 12.8) 13.0 (12.9 to 13.2) 13.7 (13.3 to 30.5)
Age, y 40.2 (12.0) 43.4 (13.2) 45.4 (13.9) 48.8 (14.7) 52.8 (15.8)
Systolic blood pressure, mm Hg 130 (17) 133 (19) 134 (20) 136 (21) 139 (23)
Diastolic blood pressure, mm Hg 75 (11) 77 (12) 78 (12) 79 (12) 80 (14)
Hypertension, %* 32.2 (1306) 33.3 (1469) 31.9 (1614) 31.2 (1843) 32.7 (2719)
Body mass index, kg/m2 24.6 (3.4) 25.0 (3.7) 25.2 (3.7) 25.3 (3.9) 25.5 (4.3)
Total cholesterol, mmol/L 5.7 (1.2) 5.9 (1.3) 6.0 (1.3) 6.2 (1.3) 6.3 (1.3)
High-density lipoprotein cholesterol, mmol/L 1.5 (0.4) 1.5 (0.4) 1.5 (0.4) 1.5 (0.4) 1.6 (0.4)
Triglycerides, mmol/L 1.5 (1.1) 1.5 (1.0) 1.6 (1.1) 1.5 (1.0) 1.5 (1.0)
Daily smoking, % 26.8 31.8 36.2 41.8 47
Self-reported diabetes, % 1.9 1.8 2.1 1.3 1.1
Hemoglobin (total), g/dL 14.1 (1.1) 14.1 (1.1) 14.1 (1.1) 14.1 (1.1) 13.7 (1.4)
Hemoglobin (women), g/dL 13.4 (0.8) 13.4 (0.8) 13.4 (0.9) 13.4 (0.9) 13.0 (1.2)
Hemoglobin (men), g/dL 15.0 (0.8) 14.9 (0.8) 14.9 (0.9) 14.8 (0.9) 14.5 (1.1)
Mean corpuscular volume, fL 89 (3.3) 89 (3.5) 89 (3.6) 89 (3.8) 88 (5.8)
Red blood cells, 91012/L 4.6 (0.4) 4.7 (0.4) 4.7 (0.4) 4.6 (0.4) 4.6 (0.4)
White blood cells, 9109/L 6.9 (1.8) 7.0 (1.9) 7.1 (2.1) 7.1 (2.0) 7.3 (2.2)
Platelets, 9109/L 251 (51) 250 (52) 250 (53) 252 (55) 260 (66)
Age at baseline and age-adjusted baseline characteristics by quintiles of red cell distribution width, expressed as means (with SD in parentheses) for continuous variables and percentages
for dichotomous variables.
*Deﬁned as systolic blood pressure ≥140 mm Hg or diastolic blood pressure ≥90 mm Hg or self-reported use of antihypertensive medication.
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triglycerides, diabetes, and red blood cell count (model 3) did
not change the risk estimate (HR 1.13; 95% CI 1.07 to 1.19).
Crude incidence rates and adjusted HRs across quintiles of
RDW and above the 95th percentile of RDW are shown in
Table 4. The risk of MI was 69% higher in the highest quintile
(quintile 5) compared with the lowest quintile (quintile 1,
model 1). Adjustment for sex, body mass index, daily
smoking, hemoglobin, white blood cells, and platelets (model
2) attenuated the risk estimate by 15% (HR 1.44; 95% CI, 1.20
to 1.72). Further adjustments for hypertension, total choles-
terol, triglycerides, diabetes, and red blood cell count (model
3) did not substantially affect the risk estimates (quintile 5:
HR 1.34; 95% CI, 1.11 to 1.60). Participants with RDW above
the 95th percentile had 94% higher risk of MI compared with
those within the lowest quintile of RDW (model 2: HR 1.94;
95% CI, 1.53 to 2.45). Further adjustments for hypertension,
total cholesterol, triglycerides, diabetes, and red blood cell
count (model 3) did not substantially alter the risk estimate
(HR 1.71; 95% CI, 1.34 to 2.20).
To investigate whether smoking modiﬁed the association
between RDW and MI, we stratiﬁed the analysis by smoking
status. The relationship between RDW and incident MI was
Table 3. Baseline Characteristics by Development of Myocardial Infarction. The Tromsø Study
Myocardial Infarction Without With
P Value
N 23 833 1779
Mean (SD) Mean (SD)
Age, y 45.2 (14.2) 62.4 (13.2) <0.001
Sex (female), % 54.4 39.3 <0.001
Systolic blood pressure, mm Hg 133 (19) 153 (24) <0.001
Diastolic blood pressure, mm Hg 77 (12) 87 (14) <0.001
Hypertension, %* 32.3 (7689) 70.9 (1262) <0.001
Body mass index, kg/m2 25.0 (3.8) 26.6 (4.1) <0.001
Total cholesterol, mmol/L 6.0 (1.3) 6.9 (1.3) <0.001
High-density lipoprotein cholesterol, mmol/l 1.5 (0.4) 1.4 (0.4) <0.001
Triglycerides, mmol/L 1.5 (1.0) 2.0 (1.2) <0.001
Daily smoking, % 36.9 (8767) 41.2 (731) <0.001
Self-reported diabetes, % 1.3 (298) 6.5 (116) <0.001
Hemoglobin (total), g/dL 14.0 (1.2) 14.4 (1.1) <0.001
Mean corpuscular volume, fL 89 (4) 89 (4) <0.001
Red blood cells, 91012/L 4.6 (0.4) 4.7 (0.4) <0.001
White blood cells, 9109/L 7.1 (2.0) 7.5 (2.2) <0.001
Platelets, 9109/L 254 (56) 247 (57) <0.001
Baseline characteristics of the population who did not and did develop myocardial infarction, expressed as means (with SD in parentheses) for continuous variables and percentages
(with numbers in parentheses) for dichotomous variables.
*Deﬁned as systolic blood pressure ≥140 mm Hg or diastolic blood pressure ≥90 mm Hg or self-reported use of antihypertensive medication.
Figure. Dose–response relationship between red cell distribu-
tion width and risk of myocardial infarction obtained by additive
Cox regression plot. The regression model is adjusted for sex,
body mass index, daily smoking, hemoglobin, white blood cells,
and platelets. The solid line shows the hazard ratio, and the
shaded area shows the 95% conﬁdence interval. The density plot
shows the distribution of red cell distribution width, and white
vertical lines indicate 2.5th, 25th, 50th, 75th and 97.5th
percentiles.
DOI: 10.1161/JAHA.114.001109 Journal of the American Heart Association 5
RDW Predicts Myocardial Infarction Skjelbakken et al
O
R
IG
IN
A
L
R
E
S
E
A
R
C
H
 at UNIVERSITETSBIBLIOTEKET I TROMSO on March 9, 2015http://jaha.ahajournals.org/Downloaded from 
modiﬁed by smoking status, and the risk estimates were
higher among smokers than among nonsmokers, although the
differences in HRs were not statistically signiﬁcant (Table 5).
In smokers, the HR for quintile 5 versus quintile 1 was 1.43
(95% CI 1.05 to 1.95), and participants with RDW above the
95th percentile had a more than 2-fold higher risk (model 3:
HR 2.28; 95% CI 1.55 to 3.35). Nonsmokers with RDW within
quintile 5 had a 34% higher risk of MI compared with quintile 1
(model 2: HR 1.34; 95% CI, 1.07 to 1.68). The association was
further weakened after additional adjustment for hyperten-
sion, total cholesterol, triglycerides, diabetes, and red blood
cell count (model 3: HR 1.21; 95% CI, 0.96 to 1.53) (Table 5).
Table 4. Adjusted Hazard Ratios for Myocardial Infarction. The Tromsø Study 1994–2010
RDW N
Median RDW,
% (range) Person-Years Event No. IR (95% CI)
Model 1* Model 2† Model 3‡
HR (95% CI) HR (95% CI) HR (95% CI)
Quintile 1 5081 12.0 (10.7 to 12.2) 68 561 158 2.3 (2.0 to 2.7) Reference Reference Reference
Quintile 2 4702 12.4 (12.3 to 12.5) 63 661 226 3.6 (3.1 to 4.0) 1.15
(0.94 to 1.41)
1.11
(0.90 to 1.36)
1.09
(0.89 to 1.34)
Quintile 3 4886 12.7 (12.6 to 12.8) 65 588 291 4.4 (3.9 to 5.0) 1.23
(1.02 to 1.50)
1.11
(0.91 to 1.35)
1.05
(0.86 to 1.28)
Quintile 4 4900 13.0 (12.9 to 13.2) 64 523 414 6.4 (5.8 to 7.1) 1.43
(1.19 to 1.72)
1.26
(1.05 to 1.52)
1.21
(1.00 to 1.46)
Quintile 5 6043 13.7 (13.3 to 30.5) 74 705 690 9.2 (8.6 to 9.9) 1.69
(1.41 to 2.01)
1.44
(1.20 to 1.72)
1.34
(1.11 to 1.60)
>95th percentile 1262 15.1 (14.4 to 30.5) 14 824 151 10.2 (8.7 to 11.9) 1.98
(1.58 to 2.48)
1.94
(1.53 to 2.45)
1.71
(1.34 to 2.20)
Crude IR per 1000 person-years and adjusted HR with 95% CI for myocardial infarction across quintiles and values above the 95th percentile (>14.3%) for RDW. IR indicates incidence rate;
HR, hazard ratio; RDW, red cell distribution width.
*Model 1: Age was used as time scale.
†Model 2: Model 1 plus sex, body mass index, daily smoking, hemoglobin, white blood cells, and platelets.
‡Model 3: Model 2 plus hypertension, total cholesterol, triglycerides, self-reported diabetes, and red blood cell count.
Table 5. Adjusted Hazard Ratios for Myocardial Infarction by Smoking. The Tromsø Study 1994–2010
Person-Years Events
Model 1* Model 2† Model 3‡
HR (95% CI) HR (95% CI) HR (95% CI)
Nonsmokers
Quintile 1 47 657 105 Reference Reference Reference
Quintile 2 42 381 140 1.04 (0.81 to 1.35) 1.00 (0.78 to 1.30) 0.97 (0.75 to 1.26)
Quintile 3 41 602 166 1.02 (0.80 to 1.31) 0.93 (0.72 to 1.19) 0.87 (0.68 to 1.12)
Quintile 4 38 209 250 1.32 (1.04 to 1.66) 1.22 (0.97 to 1.54) 1.16 (0.91 to 1.46)
Quintile 5 41 483 383 1.47 (1.17 to 1.83) 1.34 (1.07 to 1.68) 1.21 (0.96 to 1.53)
>95th percentile 8972 80 1.63 (1.21 to 2.18) 1.55 (1.14 to 2.11) 1.30 (0.94 to 1.80)
Smokers
Quintile 1 20 793 53 Reference Reference Reference
Quintile 2 21 168 86 1.24 (0.88 to 1.74) 1.25 (0.89 to 1.77) 1.25 (0.88 to 1.77)
Quintile 3 23 864 124 1.39 (1.01 to 1.93) 1.37 (0.99 to 1.91) 1.31 (0.94 to 1.82)
Quintile 4 26 127 161 1.26 (0.93 to 1.74) 1.25 (0.91 to 1.72) 1.22 (0.88 to 1.68)
Quintile 5 33 109 307 1.52 (1.14 to 2.06) 1.52 (1.12 to 2.06) 1.43 (1.05 to 1.95)
>95th percentile 5800 71 2.01 (1.41 to 2.89) 2.49 (1.71 to 3.63) 2.28 (1.55 to 3.35)
Adjusted HRs with 95% CI for myocardial infarction across quintiles and values above the 95-percentile (>14.3%) for red cell distribution width among smokers and nonsmokers.
HR indicates hazard ratio.
*Model 1: Age was used as time scale.
†Model 2: Model 1 plus sex, body mass index, hemoglobin, white blood cells, and platelets.
‡Model 3: Model 2 plus hypertension, total cholesterol, triglycerides, red blood cell count, and self-reported diabetes.
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A total of 1297 persons were anemic, according to the
World Health Organization’s deﬁnition of anemia.18 To inves-
tigate whether the association between RDW and risk of MI
was modiﬁed by anemia, we excluded participants with
anemia from the analysis. Participants in the highest quintile
of RDW without anemia had a 43% higher risk of MI (model 2:
HR 1.43; 95% CI, 1.19 to 1.72; model 3: HR 1.34; 95% CI, 1.12
to 1.62) than nonanemic participants with RDW in the lowest
quintile (Table 6). Furthermore, the risk estimates for RDW
above the 95th percentile in nonanemic participants did not
differ from those of the total population (model 2: HR 1.85;
95% CI, 1.44 to 2.39; model 3: HR 1.72; 95% CI, 1.32 to 2.22).
Discussion
Our study is, to the best of our knowledge, the ﬁrst to
demonstrate an association between RDW and risk of incident
MI in a general population. The association was consistent
when RDW was modeled both as continuous and categorical
variables, and the risk of MI by RDW displayed a dose-
dependent pattern. The presence of anemia did not affect the
risk estimates.
There are only a few previous reports on the relation
between RDW and CV diseases from general populations. A
strong association between higher RDW and CV mortality was
found in NHANES.13,14 The risk of CV death increased by 22%
for a 1-SD increment of RDW (HR 1.22; 95% CI, 1.14 to
1.31)14 and was more than 2-fold higher among participants
in the highest quintile compared with the lowest.13 In a recent
registry-based study of 225 006 patients without previous CV
events or cancer, the risk of CV events increased 39% among
patients with RDW of 16% to 17% (HR 1.39; 95% CI, 1.24 to
1.57) compared with patients with RDW <13%.19 In contrast,
RDW was not associated with MI (HR 1.05; 95% CI, 0.65 to
1.68) or myocardial mortality (HR 1.09; 95% CI, 0.96 to 1.23)
in a community-based cohort of 3226 Taiwanese participants
without a history of CV disease at enrollment.20 Greater
power to detect a signiﬁcant association between RDW and
risk of MI in our cohort may be the main reason for the
apparent discrepant relationship between RDW and MI in the
2 cohorts. It is not possible to rule out the possibility that
ethnicity or other residual confounders are unevenly distrib-
uted in the 2 cohorts.
The mechanism for the observed association between
RDW and CV morbidity and mortality remain unsettled.
Because RDW is a statistical concept, it can be assumed that
RDW is a marker of other underlying biological mechanisms.
RDW is suggested to be a biomarker reﬂecting a
proinﬂammatory condition. Oxidative stress and inﬂammation
increase RDW by impairing iron metabolism, reducing red cell
life span, and modulating the response to erythropoietin by
the bone marrow.21,22 Smoking is associated with oxidative
stress,23 and a small case-control study found that RDW was
higher in smokers than in nonsmokers24 The stronger
association between RDW and MI among smokers in our
study supports the suggestion that RDW reﬂects inﬂamma-
tion. Others have also speculated that the biological link
between RDW and CV mortality may be mediated by systemic
inﬂammation. Circulating C-reactive protein and high-
sensitivity C-reactive protein are strong predictors of
future CV events.25,26 RDW was independently associated
Table 6. Adjusted Hazard Ratios for Myocardial Infarction in Participants Without Anemia. The Tromsø Study 1994–2010
RDW N
Median RDW,
% (range)
Person-
Years
Event
No. IR (95% CI)
Model 1* Model 2† Model 3‡
HR (95% CI) HR (95% CI) HR (95% CI)
Quintile 1 4963 12.0 (10.7 to
12.2)
67 038 156 2.3 (2.0 to 2.7) Reference Reference Reference
Quintile 2 4601 12.4 (12.3 to
12.5)
62 311 222 3.6 (3.1 to 4.1) 1.15 (0.94 to
1.41)
1.11 (0.90 to
1.36)
1.09 (0.88 to
1.34)
Quintile 3 4745 12.7 (12.6 to
12.8)
63 785 288 4.5 (4.0 to 5.1) 1.24 (1.02 to
1.51)
1.11 (0.91 to
1.36)
1.06 (0.87 to
1.29)
Quintile 4 4732 13.0 (12.9 to
13.2)
62 365 405 6.4 (5.9 to 7.2) 1.45 (1.21 to
1.75)
1.27 (1.05 to
1.54)
1.23 (1.02 to
1.49)
Quintile 5 5274 13.6 (13.3 to
25.4)
65 287 631 9.7 (8.9 to 10.3) 1.73 (1.43 to
2.07)
1.43 (1.19 to
1.72)
1.34 (1.12 to
1.62)
>95th
percentile
815 14.9 (14.4 to
25.4)
9361 114 12.2 (10.1 to
14.6)
2.13 (1.67 to
2.72)
1.85 (1.44 to
2.39)
1.72 (1.32 to
2.22)
Crude IR per 1000 person years and adjusted HR with 95% CI for myocardial infarction across quintiles and values above the 95th percentile (>14.3%) for RDW in participants without
anemia (n=24 315). RDW indicates red cell distribution width; IR, incidence rate; HR, hazard ratio.
*Model 1: Age was used as time scale.
†Model 2: Model 1 plus sex, body mass index, daily smoking, hemoglobin, white blood cells, and platelet.
‡Model 3: Model 2 plus hypertension, total cholesterol, triglycerides, red blood cell count, and self-reported diabetes.
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with high-sensitivity C-reactive protein in outpatients,27 and
related to acute phase reactants such as interleukin-6 and
high-sensitivity C-reactive protein in patients with congestive
heart failure.28 However, Perlstein et al found that the
association between RDW and mortality was independent of
inﬂammation deﬁned by elevated C-reactive protein.14
Iron deﬁciency in itself is also a common cause of high
RDW. In 1981, Sullivan proposed that iron deﬁciency could
protect against MI.29 Some later studies supported this
hypothesis, whereas others did not ﬁnd any relationship or
even an inverse relationship between iron deﬁciency and
MI.30 Iron deﬁciency without anemia has been shown to
affect health issues31–33 and may speciﬁcally attenuate iron-
dependent scavenger functions of oxidative stress that may
promote inﬂammation.34 Consequently, the impact of iron
status on RDW and subsequent MI should be investigated in
future studies.
It has been reported that increased CV mortality by RDW is
conﬁned to those with anemia.20 To explore the impact of
anemia on the relationship between RDW and risk of MI in our
study, we included hemoglobin in our multivariable model
and performed analyses in which anemic participants were
excluded. The risk estimates for MI by RDW in our study were
not affected by adjustment for hemoglobin or by excluding
participants with anemia. This demonstrates that anemia does
not explain the strong association between RDW and MI.
Furthermore, results from an elderly outpatient cohort implied
that the association between extremely high RDW (>16.6%)
and mortality was particularly strong in those with nonanemic
macrocytosis (MCV >96 fL) or microcytosis (MCV <80 fL).35
We found no association between RDW and risk of MI in
nonanemic participants with macrocytosis (893 participants
with 85 MI events) or microcytosis (254 participants with 14
events).
Alternatively, RDW may exert a more direct effect in the
pathway toward MI. The erythrocytes contain large amounts
of free cholesterol,36 and pathological changes in the
erythrocyte membrane may potentially lead to accumulation
of erythrocytes within the atheromatous plaque. The erythro-
cyte membrane promotes atherosclerosis by deposition of
free cholesterol to atherosclerotic plaques, thereby providing
lipid rich membranes to foam cell formation, and by propa-
gation of the inﬂammatory cascade.37,38 Accumulation of
erythrocytes promotes plaque instability.37,39,40 The concept
is supported by higher levels of total cholesterol in the
erythrocyte membrane from patients presenting with acute
coronary syndrome compared with patients with chronic
stable angina41 and a positive association between choles-
terol content of erythrocyte membranes and RDW values in
patients with coronary disease.42 An association between the
total cholesterol content of the erythrocyte membrane and
the severity of coronary artery disease has also been
reported.43 The mechanisms whereby RDW could inﬂuence
development of atherosclerosis remain unsettled.
The erythrocyte membrane stiffness and shape inﬂuence
deformability and thereby inﬂuence blood ﬂow in the micro-
circulation.44 The ﬂow behavior of erythrocytes also affects
oxygen supply from the erythrocyte to the tissue.44 RDW
greater than 14% has been shown to decrease red blood cell
deformability.45 Consequently, impaired ﬂow properties and
oxygen supply due to high RDW may promote MI under
certain conditions. Recent studies showing that RDW is
associated with increased risk of venous thromboembo-
lism46,47 and stroke48 support the hypothesis that altered
ﬂow properties and mechanism of coagulation and thrombus
formation may potentially explain the association between
high RDW and CV diseases.
The main strength of our study is in the validated end
points of MI in a general population with high participation
and follow-up rates. The study was conducted in a relatively
homogenous population (99% white), which may limit the
generalizability of the results. Only 1 hospital serves the entire
Tromsø area, and this decreases the probability of missing
end points. In addition, all blood samples were analyzed at the
same laboratory. Because the RDW measure was not
repeated, the chance of random measurement error remains,
and the association between RDW and MI may have been
somewhat underestimated due to regression dilution bias.49
Another limitation of the study is the self-reported information
on diabetes, which probably underestimates the true preva-
lence of diabetes. Moreover, we did not have information on
kidney failure or inﬂammatory biomarkers, and this lack may
have confounded the results.
In conclusion, we found that RDW was associated with risk
of ﬁrst-time MI in a general population. The relationship was
linear and independent of anemia and traditional CV risk
factors. Whether RDW is a marker of an underlying patho-
physiological condition that leads to risk of MI or merely
represents an “innocent bystander” remains to be settled.
Future basic and epidemiological studies should aim to reveal
and understand the pathophysiological mechanisms behind
the observed association between RDW and MI.
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